Protalix BioTherapeutics, Inc. 4,500,000 Shares Common Stock ($0.001 par value) Underwriting AgreementUnderwriting Agreement • February 16th, 2012 • Protalix BioTherapeutics, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 16th, 2012 Company Industry JurisdictionJEFFERIES & COMPANY, INC. As Representative of the several Underwriters named in Schedule II hereto c/o JEFFERIES & COMPANY, INC. 520 Madison Avenue New York, New York 10022